Novavax says its vaccine protects against Omicron variant, according to early data

Novavax has been studying its vaccine’s effectiveness against the newly emerged Omicron variant of Covid-19.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.